Immunomedics Will Turn Over Sale Documents To Investors
Cancer drug developer Immunomedics Inc. on Thursday agreed to turn over documents to an investor suing the company in Delaware that detail a proposed transaction the investor says serves as an...To view the full article, register now.
Already a subscriber? Click here to view full article